Peptides for gut health research has advanced significantly over the past decade, with two compounds standing out for their mechanistic specificity and published evidence: BPC-157 and KPV
Peter de Keizer's pioneering research at Erasmus University Medical Center to its current status as a leading senolytic research tool, FOXO4-DRI demonstrates how precise molecular targeting can enable selective elimination of harmful cellular populations while preserving healthy tissue function
This is reassuring as a starting point but cannot substitute for human safety data, particularly regarding long-term use, drug interactions, and effects in people with underlying conditions
If an independent re-test ever shows a batch falls short of its stated purity, we replace it free
Users under 150 lbs may experience stronger side effects at standard doses, particularly with GLP-1 agonists
The provider was thorough and the process was seamless